Denver Investment Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Denver Investment Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,636	Closed	-$430K	–	492
2017 Q1	$430K	Sell	30,636 -1,350	-4%	-$22.1K	0.02%	355
2016 Q4	$600K	Buy	+31,986	New	+$544K	0.03%	310
2016 Q3	–	Sell	-10,406	Closed	-$140K	–	485
2016 Q2	$140K	Sell	10,406 -1,926	-16%	-$28.1K	0.01%	421
2016 Q1	$189K	Sell	12,332 -6,381	-34%	-$100K	0.01%	413
2015 Q4	$371K	Sell	18,713 -571	-3%	-$10.9K	0.02%	377
2015 Q3	$336K	Buy	19,284 +5,310	+38%	+$108K	0.01%	388
2015 Q2	$283K	Buy	+13,974	New	+$270K	0.01%	427
2014 Q4	–	Sell	-13,756	Closed	-$304K	–	663
2014 Q3	$304K	Buy	+13,756	New	+$282K	0.01%	435
2014 Q1	–	Sell	-11,279	Closed	-$114	–	694
2013 Q4	$114	Hold	11,279	–	–	﹤0.01%	542
2013 Q3	$145K	Buy	+11,279	New	+$139K	﹤0.01%	536

Other funds holding AMRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Denver Investment Advisors's AMRI Position: Q2 2017 in Review

Denver Investment Advisors sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 30,636 shares — an estimated $430K sold.

Denver Investment Advisors first reported a position in AMRI in Q3 2013 and held it in 10 quarters. The position peaked at $600K in Q4 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

Denver Investment Advisors reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
Denver Investment Advisors sold 30,636 Albany Molecular Research Inc shares in Q2 2017, an estimated $430K.
Denver Investment Advisors first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 10 quarters.
Denver Investment Advisors's Albany Molecular Research Inc position peaked at $600K in Q4 2016.
136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Denver Investment Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.